Mischel Lab in the News

November, 2011 | Cancer Discovery cover image features our research paper "Oncogenic EGFR Signaling Activates an mTORC2–NF-κB Pathway That Promotes Chemotherapy Resistance". It's also profiled in "mTORC 2:1 for Chemotherapy Sensitization in Glioblastoma" by Wolfgang Wick, Jonas Blaes, and Markus Weiler in the same issue.

Listen to the podcast: Executive Editor Mark Landis talks with Paul S. Mischel about this paper.

September 15, 2011 | Research paper "An LXR Agonist Promotes Glioblastoma Cell Death through Inhibition of an EGFR/AKT/SREBP-1/LDLR–Dependent Pathway" published in Cancer Discovery was profiled by a number of news media.

  JAMA News: Blocking choresterol could eliminate deadly brain cancer cells
  AACR Public & Media: Targeting cholesterol may help slow glioblastoma
  Ivanhoe News:Targeting cholesterol to fight brain cancer
  UCLA Newsroom: Blocking cholesterol in brain cancer cells may offer new strategy to fight deadly glioblastoma

July 23, 2010 |  Dr. Mischel was quoted in Ivanhoe News " Starving Brain Cancer". His full length interview with Ivanhoe can be found here.|  Work on  coupling treatment with molecular diagnostics discussed in the NCI Cancer Bulletin. Click here to view article

June 9, 2010 | Work on Cencer Cell Metabolism profiled in JAMA. Click here to view article

December 2009 | Inhibitors of fatty acid signaling promote apoptosis in gliobastoma cells with highly active EGFR Signaling.

         Boston Globe - Click here to view the article

         JCCC - Click here to view the article

         NIH - Click here to view the article

April 2008 |  Dr. Mischel was elected Vice President of ASCI.

January 2008 |  Dr. Mischel was quoted in the la times about brain cancer vaccines. Click here to view the article

October 2007 |  The Mischel lab and Tseng lab were recognized and awarded with the nci alliance for nanotechnology in cancer poster award winner for the 2007 nci alliance for nanotechnology in cancer investigators meeting taking place in Chapel Hill, NC. 
Click Here to view Award Picture.

July 2007 |  Dr. Mischel was acknowledged in the irish cancer society news, highlight spring/summer 2007 for his work on the treatment of adult brain tumors.

Dec. 2006 |  Dr. Mischel has been selected as the 2007 Farber Award winner for excellence in neuro-oncology. The Farber Lectureship recognizes a promising new investigator who has achieved significant results early in his or her career. The honor includes an award of $10,000. [
UCLA Today Online Article]

Jun. 2006 | Our glioblastoma/genetic analysis paper has been featured in a new fact sheet put out by NIH.

May 2006 | Mischel laboratory publishes a highlighted article in the May issue of Nature Clinical Practice Neurology.

May 2006 |
UCLA Neuro-Oncology homepage features coverage of EGFR/PTEN study titled "Improving clinical outcomes in glioblastoma brain tumors with genetic analysis."
 

Mar. 2006 | UCLA/Duke/Broad Institute team is awarded a Brain Tumor Funders’ Collaborative Grant. Dr. Mischel is PI of the research project titled "Molecularly Guided Clinical Trials for Glioma".

Dec. 2005 | Our EGFR/PTEN study is covered by The Lancet Oncology vol. 6 December 2005.

Nov. 10, 2005 |
USA Today covers our New England Journal of Medicine (NEJM) article. Click here for USA Today report; click here for NEJM paper.

Oct. 2005 | UCLA/Cal Tech/Institute for Systems Biology Team awarded an NIH Center of Cancer Nanotechnology Excellence. Dr. Mischel is PI of one of the projects on this Nanosystems grant. (NanotechNanosystems Biology Cancer Center: http://www.caltechcancer.org/)
 

Click here to visit the
Irish Cancer
Society Website